Your browser doesn't support javascript.
loading
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.
Moreno, Lucas; Casanova, Michela; Chisholm, Julia C; Berlanga, Pablo; Chastagner, Pascal B; Baruchel, Sylvain; Amoroso, Loredana; Gallego Melcón, Soledad; Gerber, Nicolas U; Bisogno, Gianni; Fagioli, Franca; Geoerger, Birgit; Glade Bender, Julia L; Aerts, Isabelle; Bergeron, Christophe; Hingorani, Pooja; Elias, Ileana; Simcock, Mathew; Ferrara, Stefano; Le Bruchec, Yvan; Slepetis, Ruta; Chen, Nianhang; Vassal, Gilles.
Afiliação
  • Moreno L; Hospital Infantil Universitario Niño Jesús, Madrid, Spain. Electronic address: lucas.moreno@salud.madrid.org.
  • Casanova M; Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Chisholm JC; Royal Marsden Hospital, Sutton, UK.
  • Berlanga P; Unidad de Oncologia Pediatrica, Hospital Universitario I Politècnic La Fe, Valencia, Spain.
  • Chastagner PB; Hôpital d'Enfants, Nancy, France.
  • Baruchel S; The Hospital for Sick Children, Toronto, ON, Canada.
  • Amoroso L; IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Gallego Melcón S; Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Gerber NU; University Children's Hospital, Zurich, Switzerland.
  • Bisogno G; Department of Pediatrics, Hematology/Oncology Division, Padova, Italy.
  • Fagioli F; Pediatric Onco-Hematology Division, Regina Margherita, Torino, Italy.
  • Geoerger B; Gustave Roussy, Department of Pediatric and Adolescent Oncology, Villejuif, France.
  • Glade Bender JL; Columbia University, New York, NY, USA.
  • Aerts I; Institut Curie, PSL Research University, Oncology Center SIREDO (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Paris, France.
  • Bergeron C; Department of Pediatrics, Centre Léon Bérard, Lyon, France.
  • Hingorani P; Phoenix Children's Hospital, Phoenix, AZ, USA.
  • Elias I; Celgene Corporation, Toronto, ON, Canada.
  • Simcock M; Celgene International, Boudry, Switzerland.
  • Ferrara S; Celgene International, Boudry, Switzerland.
  • Le Bruchec Y; Celgene International, Boudry, Switzerland.
  • Slepetis R; Celgene Corporation, Summit, NJ, USA.
  • Chen N; Celgene Corporation, Summit, NJ, USA.
  • Vassal G; Gustave Roussy, Villejuif, France.
Eur J Cancer ; 100: 27-34, 2018 09.
Article em En | MEDLINE | ID: mdl-29936064
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paclitaxel / Albuminas / Neoplasias / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: America do norte / Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paclitaxel / Albuminas / Neoplasias / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: America do norte / Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article